Dipna Pharmachem share price
BSE: 543594Pharmaceuticals & BiotechnologySmall Cap
DIPNA PHARMACHEM LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2022
Last close ₹3.79down ₹0.10 (2.57%)
Share price at the BSE close on 27 Oct 2026. Previous close ₹3.89.
27 Oct: open ₹3.90, high ₹3.90, low ₹3.72
52-week range of traded prices to 27 Oct 2026
₹3.72Low, 27 Oct 2026₹20.50High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9.96 Cr3,953rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 33,000
Results
Standalone; ₹ crore.Dipna Pharmachem quarterly results
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹129 Crup 3.34%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹2.63 Crup 170.19%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 2.0%
Revenue by year
Peak revenue ₹164 Cr, year to Mar 2024; lowest ₹100 Cr, year to Mar 2023
Net profit by year, a loss in red
| ₹ crore | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 100 | 164 | 125 | 129 |
| Net profit | 1 | 1 | 1 | 3 |
| Net margin | 0.9% | 0.7% | 0.8% | 2.0% |
Standalone. Years to March. The latest is shaded.
Quarter to Mar 2026
- Revenue
- ₹2.02 Cr
- Net profit
- ₹0.18 Cr
- Net margin
- 8.8%
| ₹ crore | Mar 2026 |
|---|---|
| Revenue | 2.02 |
| Net profit | 0.18 |
| Net margin | 8.8% |
Standalone. The quarter to Mar 2026, the first on record; the half years before it are below.
| ₹ crore | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 90.6 | 34.3 | 72.3 |
| Net profit | 0.3 | 0.6 | 1.4 |
| Net margin | 0.4% | 1.9% | 2.0% |
Standalone. The half years in the same span that the quarters on record do not fully cover.
Business segments
Share of revenue, year to Mar 2026, standalone.Segment revenue and profit
- Steel SegmentSteel Segment, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹70.9 Cr54.9%
- Chemicals SegmentChemicals Segment, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹58.2 Cr45.1%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −43.9% | +143.9% | −77.0% | 0.0% |
| 3 years | −13.9% | +9.6% | −21.4% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Dipna Pharmachem competitors and peers
Pharmaceuticals, 216 listed companies, priced on 27 Oct 2026. The table lists the 7 companies closest to Dipna Pharmachem in market cap. 2 companies in the table last traded before then: their rows are priced on their last trade.Healthcare companies
Dipna Pharmachem is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Desh Rakshak AushdhalayaDESHRAK | 15 | 27.77 | 1.15 | −24.3% | – | 4.7% | 5.8% | 0.00% |
 Beryl DrugsBERLDRG | 12 | 19.29 | 1.22 | +8.3% | +169.1% | 6.4% | 3.1% | 0.00% |
 Unjha FormulationsUNJHAFOR | 12 | 24.71 | 3.03 | +13.0% | +386.7% | 13.5% | 15.2% | 0.00% |
 Ortin GlobalORTINGLOBE | 10 | – | 8.38 | −58.3% | – | −56.2% | −52.2% | 0.00% |
 Brawn BiotechBRAWN | 8 | 8.87 | 1.76 | +13.6% | – | 22.3% | −12.6% | 0.00% |
 Vivanza BiosciencesVIVANZA | 6 | 13.74 | 1.43 | +735.0% | – | 10.9% | 3.3% | 0.00% |
 Decipher LabsDECIPHER | 5 | – | 0.62 | −25.2% | – | – | −31.5% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Dipna Pharmachem announcements
Oct 2026
24 Oct · Management
24 Oct · Management
23 Oct · Management
Dipna Pharmachem share price by year
Each calendar year to 2025.Dipna Pharmachem share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 16.90 | +17.3% | 25.79 | 11.74 |
| 2024 | 14.41 | +35.3% | 16.83 | 6.68 |
| 2023 | 10.65 | −47.8% | 28.64 | 10.65 |
| 2022 | 20.40 | – | 33.40 | 19.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2022 is from its first session, 8 Sep 2022.
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 26 Oct 2026 | 3.80 | 3.89 | 3.80 | 3.89 | 3.83 | 12,000 |
| 23 Oct 2026 | 3.90 | 3.90 | 3.89 | 3.89 | 3.90 | 18,000 |
| 22 Oct 2026 | 4.05 | 4.05 | 3.90 | 3.93 | 3.94 | 30,000 |
| 21 Oct 2026 | 4.05 | 4.05 | 4.05 | 4.05 | 4.05 | 6,000 |
| 19 Oct 2026 | 4.06 | 4.09 | 4.05 | 4.06 | 4.07 | 12,000 |
| 16 Oct 2026 | 4.09 | 4.16 | 3.97 | 3.97 | 4.09 | 27,000 |
| 15 Oct 2026 | 4.04 | 4.09 | 4.04 | 4.05 | 4.05 | 21,000 |
| 14 Oct 2026 | 4.17 | 4.17 | 4.02 | 4.04 | 4.06 | 1,08,000 |
| 13 Oct 2026 | 4.36 | 4.54 | 4.06 | 4.17 | 4.23 | 84,000 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Rights issue history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 12 Feb 2024 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
Each event is noted and not adjusted for.
Company details
- BSE code
- 543594
- ISIN
- INE0MC401013
- Industry
- Pharmaceuticals & Biotechnology
- Website
- www.dipnapharmachem.com
- CIN
- L24100GJ2011PLC066400
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2011
- Registered office
- A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad 380055, Gujarat
- Share registrar
- Bigshare Services Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments